The Role of Advanced Practice Providers in the Care of Nonalcoholic Fatty Liver Disease

被引:2
|
作者
Gajos, Andrea [1 ]
Tapper, Elliot B. [1 ,2 ]
机构
[1] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Gastroenterol Sect, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
cirrhosis; obesity; liver transplant; patient centered care; RANDOMIZED CONTROLLED-TRIAL; WEIGHT-LOSS; CIRRHOSIS; EPIDEMIOLOGY; EFFICACY; QUALITY; ADULTS;
D O I
10.1016/j.clinthera.2020.12.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the United States. NAFLD presents unique challenges to conventional health care delivery. Patients require accurate, efficient risk stratification to both individualize clinical management plans and optimize subspecialty resource allocation The hepatology workforce is grossly outmatched by the demand for NAFLD referrals, however. Advanced practice providers (APPs) may be best suited to meeting the challenges of NAFLD care. This article reviews the nature and scope of APP practice, the specific needs posed by NAFLD, and the evidence supporting the comparative advantages of APPs in optimizing the outcomes of patients with NAFLD. Our goal is to show how APPs are uniquely suited to addressing the needs of patients with NAFLD who are seen in hepatology practice, with an emphasis on training philosophy and behavioral intervention. (C) 2020 Elsevier Inc.
引用
收藏
页码:518 / 523
页数:6
相关论文
共 50 条
  • [21] Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice
    Augustin, Salvador
    Ahmed, Aijaz
    Alkhouri, Naim
    Canbay, Ali
    Corless, Lynsey
    Nakajima, Atsushi
    Okanoue, Takeshi
    Petta, Salvatore
    Ratziu, Vlad
    Tsochatzis, Emmanuel A.
    Wong, Vincent Wai-Sun
    Romero-Gomez, Manuel
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2020, 29 (02) : 235 - 245
  • [22] The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Shouhed, Daniel
    Steggerda, Justin
    Burch, Miguel
    Noureddin, Mazen
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (09) : 797 - 811
  • [23] The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Cha J.-Y.
    Kim D.-H.
    Chun K.-H.
    Laboratory Animal Research, 2018, 34 (4) : 133 - 139
  • [24] The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Chow, Monica D.
    Lee, Yi-Horng
    Guo, Grace L.
    MOLECULAR ASPECTS OF MEDICINE, 2017, 56 : 34 - 44
  • [25] Nonalcoholic fatty liver disease with advanced fibrosis, stroke and cardiovascular disease
    Kawada, Tomoyuki
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 408
  • [26] Role of extracellular vesicles in nonalcoholic fatty liver disease
    Jiang, Wei
    Xu, Youhui
    Chen, Jou-Chen
    Lee, Yi-Hung
    Hu, Yushin
    Liu, Chang-Hai
    Chen, Enqiang
    Tang, Hong
    Zhang, Hua
    Wu, Dongbo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [27] Emerging role of carboxylesterases in nonalcoholic fatty liver disease
    Liu, Jie
    Yao, Bingyi
    Gao, Liangcai
    Zhang, Yuanjin
    Huang, Shengbo
    Wang, Xin
    BIOCHEMICAL PHARMACOLOGY, 2022, 205
  • [28] Role of TWEAK in the Pathogenesis of Nonalcoholic Fatty Liver Disease
    Polat, Zulfikar
    Uygun, Ahmet
    Ozel, A. Melih
    Basaranoglu, Metin
    Aslan, Fatih
    Gulsen, Mustafa
    Bagci, Sait
    GASTROENTEROLOGY, 2013, 144 (05) : S1011 - S1012
  • [29] Role of cenicriviroc in the management of nonalcoholic fatty liver disease
    Georgios Neokosmidis
    Konstantinos Tziomalos
    World Journal of Gastroenterology, 2018, (48) : 5415 - 5417
  • [30] The role of exosomal miRNA in nonalcoholic fatty liver disease
    Mahmoudi, Ali
    Butler, Alexandra E.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (04) : 2078 - 2094